Stock NPWA SMITH & NEPHEW PLC
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Smith & Nephew plc Deutsche Boerse AG

Equities

NPWA

US83175M2052

Delayed Deutsche Boerse AG
Other stock markets
 02:01:39 2024-06-04 am EDT 		5-day change 1st Jan Change
23 EUR -0.86% Intraday chart for Smith & Nephew plc +0.88% -6.50%
May. 31 SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%) Alphavalue
May. 14 European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading MT

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
SMITH & NEPHEW PLC Stock Smith & Nephew plc
-6.50% 10.98B -
STRYKER CORPORATION Stock Stryker Corporation
+14.22% 129B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-1.95% 8.22B
C
GLAUKOS CORPORATION Stock Glaukos Corporation
+40.86% 5.76B
B+
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-27.27% 4.41B
C
AXONICS, INC. Stock Axonics, Inc.
+7.52% 3.41B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-15.19% 2.7B
B-
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-10.70% 2.1B - -
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-14.30% 1.91B -
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-29.81% 1.62B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. SN. Stock
  4. NPWA Stock
  5. Ratings Smith & Nephew plc